1. Home
  2. SLS vs GENC Comparison

SLS vs GENC Comparison

Compare SLS & GENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • GENC
  • Stock Information
  • Founded
  • SLS 2012
  • GENC 1894
  • Country
  • SLS United States
  • GENC United States
  • Employees
  • SLS N/A
  • GENC N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • GENC Construction/Ag Equipment/Trucks
  • Sector
  • SLS Health Care
  • GENC Industrials
  • Exchange
  • SLS Nasdaq
  • GENC Nasdaq
  • Market Cap
  • SLS 238.7M
  • GENC 205.4M
  • IPO Year
  • SLS N/A
  • GENC N/A
  • Fundamental
  • Price
  • SLS $1.92
  • GENC $13.92
  • Analyst Decision
  • SLS Strong Buy
  • GENC
  • Analyst Count
  • SLS 1
  • GENC 0
  • Target Price
  • SLS $7.00
  • GENC N/A
  • AVG Volume (30 Days)
  • SLS 4.7M
  • GENC 20.9K
  • Earning Date
  • SLS 11-12-2025
  • GENC 08-08-2025
  • Dividend Yield
  • SLS N/A
  • GENC N/A
  • EPS Growth
  • SLS N/A
  • GENC N/A
  • EPS
  • SLS N/A
  • GENC 1.03
  • Revenue
  • SLS N/A
  • GENC $117,527,000.00
  • Revenue This Year
  • SLS N/A
  • GENC N/A
  • Revenue Next Year
  • SLS N/A
  • GENC N/A
  • P/E Ratio
  • SLS N/A
  • GENC $13.47
  • Revenue Growth
  • SLS N/A
  • GENC 3.90
  • 52 Week Low
  • SLS $0.77
  • GENC $10.80
  • 52 Week High
  • SLS $2.48
  • GENC $22.82
  • Technical
  • Relative Strength Index (RSI)
  • SLS 51.34
  • GENC 43.64
  • Support Level
  • SLS $1.86
  • GENC $13.76
  • Resistance Level
  • SLS $2.06
  • GENC $14.20
  • Average True Range (ATR)
  • SLS 0.16
  • GENC 0.42
  • MACD
  • SLS -0.02
  • GENC 0.05
  • Stochastic Oscillator
  • SLS 11.90
  • GENC 21.61

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.

Share on Social Networks: